SEC Form 4 · accession 0001179110-16-032290
DAVITA INC. · DVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Javier Rodriguez
Officer — CEO-Kidney Care
Period of report
Nov 30, 2016
Accepted (ET)
Dec 1, 2016 · 9:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000927066
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 30, 2016 | M | 80,000 | $36.96 | A | 144,264 | D | |
| Common Stock | Nov 30, 2016 | F | 46,447 | $63.66 | D | 97,817 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightsF1 | $36.96 | Nov 30, 2016 | M | 80,000 | D | — | Dec 8, 2016 | Common Stock | 80,000 | 0 | D |
Explanation of responses
- F1The Stock Appreciation Rights were granted on 12/8/2011, and vested in three equal installments on 12/8/2013, 12/8/2014 and 12/8/2015, respectively.